WATERTOWN, Mass.--(BUSINESS WIRE)--Tetraphase Pharmaceuticals, Inc., a clinical-stage life science company developing a portfolio of potent new antibiotics designed to be effective against dangerous, drug-resistant bacteria (including multidrug-resistant (MDR) gram-negative pathogens), today announced that the Company will present at the Cowen and Company 32nd Annual Health Care Conference. Tetraphase President and CEO Guy Macdonald will present for the company at 4:00 p.m. (ET) on Tuesday, March 6, 2012. The Conference will take place at The Boston Marriott Copley Place in Boston, Massachusetts.